Annovis Bio Quote - ANVS

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

28.23

Bid

Offer

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

289.696M

Previous Close

28.23

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

10,262,000

Dividend Yield

PE Ratio

-0.32

Earnings Per Share (EPS)

-5.48

Revenue

Net Profit

-56.2M

Annovis Bio Inc is a clinical stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neuro degenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. Annovis Bio Inc is a clinical stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neuro degenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.annovisbio.com

Headquarters

Dover, Delaware, USA

Founded

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ANVS - Frequently Asked Questions (FAQ)

What is the current Annovis Bio share price?

The current share price of Annovis Bio is US$ 28.23

How many Annovis Bio shares are in issue?

Annovis Bio has 10,262,000 shares in issue

What is the market cap of Annovis Bio?

The market capitalisation of Annovis Bio is USD 289.7M

What is the 1 year trading range for Annovis Bio share price?

Annovis Bio has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Annovis Bio?

The price to earnings ratio of Annovis Bio is -0.32

What is the reporting currency for Annovis Bio?

Annovis Bio reports financial results in USD

What is the latest annual profit for Annovis Bio?

The latest annual profit of Annovis Bio is USD -56.2M

What is the registered address of Annovis Bio?

The registered address for Annovis Bio is 1111B S GOVERNORS AVENUE, KENT, DOVER, DELAWARE, 19904

What is the Annovis Bio website address?

The website address for Annovis Bio is www.annovisbio.com

Which industry sector does Annovis Bio operate in?

Annovis Bio operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KNWKnow Labs Inc	US$ 2.222 (2,495.79%)	254.56k
MMAMixed Martial Arts Group Limited	US$ 0.80 (31.15%)	91.3k
SACHSachem Capital Corporation	US$ 1.33 (16.67%)	782.98k
ARMUT REX 2X Long ARM Daily Target ETF	US$ 27.08 (14.33%)	3.8k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 18.47 (11.33%)	33.35M
IBOImpact Biomedical Inc	US$ 0.93 (-23.14%)	42.42k
ATCHAtlasClear Holdings Inc	US$ 1.36 (-13.92%)	802.48k
GOROGold Resource Corporation	US$ 0.5213 (-13.12%)	9.96M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 6.0701 (-11.51%)	89.39M
LLYXDefiance Daily Target 2X Long LLY ETF	US$ 22.03 (-9.53%)	228.21k
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 20.88 (8.58%)	137.51M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6.69 (-1.47%)	119.57M
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 6.0701 (-11.51%)	89.39M
XLFFinancial Select Sector	US$ 49.12 (-0.53%)	83.35M
SPYSPDR S&P 500	US$ 575.92 (0.56%)	78.29M